Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats

Psychopharmacology

Volumn 135, Issue 4, 1998, Pages 324-332

  Chaperon, Frédérique ^a   Soubrié, Philippe ^b   Puech, Alain J ^a   Thiébot, Marie Hélène ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SANOFI   (France)

Author keywords

Cannabinoid receptors; Cocaine; Food; Incentive learning; Morphine; Rat; Reward; SR 141716; WIN 55212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; COCAINE; MORPHINE; RIMONABANT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG DEPENDENCE; DRUG MECHANISM; DRUG POTENTIATION; DRUG RECEPTOR BINDING; FOOD INTAKE; MALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REINFORCEMENT;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CANNABINOIDS; COCAINE; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; MALE; MORPHINE; MORPHOLINES; MOTOR ACTIVITY; NAPHTHALENES; NARCOTICS; PIPERIDINES; PYRAZOLES; RATS; RATS, WISTAR; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

EID: 0031780582     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050518     Document Type: Article

References (38)

1. Arnone M, Maruani J, Chaperon F, Thiébot MH, Poncelet M, Soubrié P, Le Fur G (1997) Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptor. Psychopharmacology 132:104-106
2. Beninger R, Herz R (1986) Pimozide blocks establishment but not expression of cocaine-induced environment-specific conditioning. Life Sci 38:1425-1431
3. Bozarth M (1991) The mesolimbic dopamine system as a model of reward system. In: Willner P, Scheel-Krüger J (eds) The mesolimbic dopamine system: from motivation to action. Wiley, Chichester, pp 301-330
4. Carr GD, Fibiger HG, Phillips AG (1989) Conditioned place preference as a measure of drug reward. In: Liebman JM, Cooper SJ (eds) The neuropharmacological basis of reward. Clarendon Press, Oxford, pp 264-319
5. Castaǹeda E, Moss DE, Oddie SD, Whishaw IQ (1991) THC does not affect striatal dopamine release: microdialysis in freely moving rats. Pharmacol Biochem Behav 40:587-591
6. Cervo L, Samanin R (1995) Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference. Brain Res 673:242-250
7. 3-receptor preferring ligands on the acquisition of place conditioning in rats. Behav Pharmacol 7:105-109
8. 9-Tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology 102:156-162
9. 9-Tetrahydrocannabinol enhances presynaptic dopamine efflux in medial prefrontal cortex. Eur J Pharmacol 190:259-262
10. 9-tetrahydrocannabinol-induced responses and apparent agonist activity. J Pharmacol Exp Ther 277:586-594
11. Corcoran M, Amit Z (1974) Reluctance of rats to drink hashish suspensions: free-choice and forced consumption, and the effects of hypothalamic stimulation. Psychopharmacologia 35:129-147
12. Gardner E, Paredes W, Smith D, Donner A, Milling C, Cohen D, Morrison D (1988) Facilitation of brain stimulation reward by delta-9 tetrahydrocannabinol. Psychopharmacology 96:142 144
13. Gough AL, Olley JE (1977) Δ9-Tetrahydrocannabinol and the extrapyramidal system. Psychopharmacology 54: 87 99
14. Guyon A, Assouly-Besse F, Biala G, Puech AJ, Thiébot MH (1993) Potentiation by low doses of selected neuroleptics of food-induced conditioned place preference in rats. Psychopharmacology 110:460-466
15. Harris RT, Waters W, McLendon D (1974) Evaluation of reinforcing capability of delta-9-tetrahydrocannabinol in monkeys. Psychopharmacology 37:23-29
16. Hollister L (1986) Health aspects of cannabis. Pharmacol Rev 38: 1-19
17. Howlett A (1995) Pharmacology of cannabinoid receptors. Annu Rev Pharmacol Toxicol 35:607-634
18. Leite JR, Carlini EA (1974) Failure to obtain "cannabis-directed behavior" and abstinence syndrome in rats chronically treated with Cannabis sativa extracts. Psychopharmacologia 35:133 145
19. 9-telrahydrocannabinol: comparison with cocaine, morphine, and food reward. Life Sci 56:2073 2080
20. 9-Tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism. Psychopharmacology 126:125 131
21. Lichtman AH, Martin BR (1997) The selective cannabinoid antagonist SR 141716A blocks cannabinoid-induced antinociception in rats. Pharmacol Biochem Behav 57:7 12
22. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561 564
23. McGregor IS, Issakidis CN, Prior G (1996) Aversive effects of the synthetic cannabinoid CP 55,940 in rats. Pharmacol Biochem Behav 53:657 664
24. Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61 65
25. Onaivi ES, Green MR, Martin BR (1990) Pharmacological characterization of cannabinoids in the elevated plus maze. J Pharmacol Exp Ther 253: 1002 1009
26. Parker LA, Gillies T (1995) THC-induced place and taste aversion in Lewis and Sprague-Dawley rats. Behav Neurosci 109:71 78
27. Pério A, Rinaldi-Carmona M, Maruani J, Barth F, Le Fur G, Soubrie P (1996) Central mediation of the cannabinoid cue: activity of a selective CB1 antagonist, SR 141716A. Behav Pharmacol 7:65-71
28. Rinaldi-Carmona M, Barth F, Héaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Néliat G, Caput D, Ferrara P, Soubrié P, Brelière JC, Le Fur G (1994) SR 141716A. a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350:240-244
29. Rinaldi-Carmona M, Barth F, Héaulme M, Alonso R, Shire D, Congy C, Soubrié P, Brelière JC, Le Fur G (1995) Biochemical and pharmacological characterisation of SR 141716A the first potent and selective brain cannabinoid receptor antagonist. Life Sci 56:1941 1947
30. 9-Tetrahydrocannabinol elicited ipsilateral circling behavior in rats with unilateral nigral lesion. Life Sci 37:2181 2185
31. Santucci V, Storme JJ, Soubrié P, Le Fur G (1996) Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716 in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis. Life Sci 58:103 110
32. Sañudo-Peña MC, Tsou K, Delay ER, Hohman AG, Force M, Walker JM (1997) Endogenous cannabinoids as an aversive or counter-rewarding system in the rat. Neurosci Lett 223:125 128
33. Showalter VM, Compton DR, Martin BR, Abood ME (1996) Evaluation of binding in transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. J Pharmacol Exp Ther 278:989-998
34. Souilhac J. Poncelet M, Rinaldi-Carmona M, Le Fur G, Soubrié P (1995) Intrastriatal injection of cannabinoid receptor agonists induced turning behavior in mice. Pharmacol Biochem Behav 51:3 7
35. Takahashi RN, Singer G (1979) Self-administration of delta 9-tetrahydrocannabinol by rats. Pharmacol Biochem Behav 11:737 740
36. Terranova J-P, Storme J-J. Lafon N, Pério A, Rinaldi-Carmona M, Le Fur G, Soubrié P (1996) Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716. Psychopharmacology 126:165 172
37. Wiley JL, Barrett RL, Lowe J, Balster RL, Martin BR (1995a) Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats. Neuropharmacology 34: 669 676
38. Wiley JL, Lowe JL, Balster RL, Martin BR (1995b) Antagonism of the discriminative stimulus ellects of delta 9-tetrahydrocannabinol in rats and rhesus monkeys. J Pharmacol Exp Ther 275:1 6